Soros Fund Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-156,053
| Closed | -$12.8M | – | 175 |
|
|
2024
Q2 | $12.8M | Buy |
156,053
+153
| +0.1% | +$12.6K | 0.23% | 85 |
|
|
2024
Q1 | $13.6M | Buy |
+155,900
| New | +$13.6M | 0.23% | 80 |
|
|
2017
Q3 | – | Sell |
-2,500
| Closed | -$227K | – | 220 |
|
|
2017
Q2 | $227K | Buy |
+2,500
| New | +$227K | ﹤0.01% | 172 |
|
|
2016
Q4 | – | Sell |
-5,734
| Closed | -$531K | – | 204 |
|
|
2016
Q3 | $531K | Buy |
+5,734
| New | +$531K | 0.01% | 150 |
|